Massachusetts Biotech News (United States)

Cambridge Healthtech Institute announces the Ninth Annual Strategic Alliance Management Congress scheduled May 7-9, 2012. The theme to this year’s congress is Advancing Pharmaceuticals & Companion Diagnostics through Collaboration & Partnerships.

Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference.

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx.

Event Focus will be Predicting Biological and Kinetic Profiles from Structure

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Agenda Announcement and Registration Reminder for CHI’s Eighth Annual PEGS the essential protein engineering summit, April 30 – May 4, Boston, MA

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.

Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference.

Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA.

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

Cambridge Healthtech Institute & Bio-IT World organizes a two hour dinner short course on June 7, 2012, Royal Sonesta Hotel Boston, Cambridge, MA. The course will be held at the conclusion of day two of the Structure-Based Drug Design conference.

New Pharmaceuticals research report from Markets and Markets is now available from Fast Market Research

Cambridge Healthtech Institute announces the Ninth Annual Strategic Alliance Management Congress scheduled May 7-9, 2012. The theme to this year’s congress is Advancing Pharmaceuticals & Companion Diagnostics through Collaboration & Partnerships.

This course will be held on June 4, 2012, Loews Hotel, Philadelphia, PA. The course will be held prior to the start of CHI’s Innovative Tissue-Based Diagnostics conference.

Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference.

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.

Join 150+ delegates involved in IT and informatics at pharma, biotech & academic institutions at CHI’s Molecular Med TRI-CON 2012 event on Feb. 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. www.TriConference.com/IRD.

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx.

Event Focus will be Predicting Biological and Kinetic Profiles from Structure

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Agenda Announcement and Registration Reminder for CHI’s Eighth Annual PEGS the essential protein engineering summit, April 30 – May 4, Boston, MA

A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.

CHI's Fifth Annual Protein-Protein Interactions: Targeting PPI for Therapeutic Interventions will be held April 18-19, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount ends January 27th.

Cambridge Healthtech Institute’s Third Annual Anti-Inflammatories: Small Molecule Approaches will be held April 17-18, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount expires January 27th.

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.

CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.

Fast Market Research recommends "Acute Myeloid Leukemia Therapeutics Market (2010 - 2020) (Pipeline Assessment & Market Forecast in G8 Countries)" from Markets and Markets, now available

New Pharmaceuticals market report from Markets and Markets: "Global Prostate Cancer Therapeutics Market (2010 - 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)"

New Pharmaceuticals research report from Espicom Business Intelligence is now available from Fast Market Research

Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning).

CHI’s Event Short Course is being held at the Molecular Med TRI-CON 2012 on February 20th at The Moscone North Convention Center in San Francisco.

The global market for advanced drug delivery systems is estimated to reach nearly $137.9 billion in 2011 and $175.6 billion by 2016 at a compound annual growth rate (CAGR) of 5%.

Chris Porter, Product Manager, HPC Cloud, will lead a luncheon presentation at CHI’s Cloud Computing: Applications and Advances in Life Sciences R&D Symposium next month in San Francisco, CA.

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

Event Focusing on Novel Small Molecules as Therapeutic Targets

Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA.

Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!

Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia at 19th International Molecular Med Tri-CON 2012.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference.

NGS Leaders community to host industry discussion on key challenge of next-generation sequencing data

Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA.

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

Discussions led by industry experts, such as Malcolm Young (e-Therapeutics), Jeremy Jenkins (Novartis), and John Burke (Boehringer Ingleheim) will address the implementation of de-risking approaches into the corporate organization.

Navigating the Future of Genomic Technologies. March 5-8, 2012 at the Hilton San Diego Resort

When: November 17-18, 2011 Where: Omni Parker House - Boston, MA

CHI’s Integrated R&D Informatics conference will once again be held at the Molecular Med TRI-CON 2012 on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Tri-Conference.

Cambridge Healthtech Institute Announces 11th Annual PepTalk: The Protein Science Week, January 9 – 13, 2012 in San Diego, CA

Global market for biotech separation systems to reach nearly $26.7 billion in 2016

Hear strategies addressing the role of miRNA in human development and disease, and to explore the impact of this new research for drug and diagnostic development.

CHI’s Oncology Clinical Trials: Bringing Targeted & Tailored Cancer Therapy will take place on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2012.

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

A 2-day Symposium on "Cloud Computing: Applications and Advances in Life Sciences R&D" will take place on Feb. 19-20, 2012 at the InterContinental Hotel, San Francisco. This symposium is part of many offerings at the Molecular Med TRI-CON 2012.